Rosenblatt Maintains Buy on Imax, Raises Price Target to $50

Benzinga Newsdesk www.benzinga.com Positive 66.0%

Neg 0% Neu 0% Pos 66%

Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $47 to $50.

Comments

No comments yet. Be the first!